Compare Nano Dimension Ltd - ADR (NNDM) vs Tempus AI (TEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nano Dimension Ltd - ADR vs Tempus AI — how do they compare? Nano Dimension Ltd - ADR trades at $1.56 (market cap $328.52M), while Tempus AI trades at $69.85 (market cap $12.58B). The key difference: Tempus AI is far larger — about 38.3× Nano Dimension Ltd - ADR's market cap, and Tempus AI is trading nearer its 52-week high, Nano Dimension Ltd - ADR nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Nano Dimension Ltd - ADR for 43 Days and Tempus AI for 22 Days on average.
| NNDM | TEM | |
|---|---|---|
Market Cap | $328.52M | $12.58B |
Volume | 1,160,945 | 7,444,569 |
Sector | Technology | Broad Market / Factor |
52-Week High | $2.14 | $99.28 |
52-Week Low | $1.21 | $41.55 |
Typical Hold Time | 43 Days | 22 Days |
Enterprise Value | -$76.33M | $13.21B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Nano Dimension (NNDM) trades at $1.55, down 1.27% with a bearish technical signal. The company shows concerning fundamentals with a net income margin of -135.18% and negative cash flow from operations of -$101.28M in 2025. Recent strategic actions include cost-saving initiatives and board restructuring, while technical indicators show mixed signals with neutral oscillators but bearish moving averages.
The outlook remains challenging with persistent losses and cash burn despite revenue growth. Investment opportunity exists in the company's strategic repositioning and cash preservation efforts, but risks include continued operational losses, competitive pressures, and execution uncertainty in the additive manufacturing sector.
Tempus AI (TEM) trades at $70.29, down 2.35% on the day, with a bullish technical signal despite recent weakness. The company reported Q2 2026 revenue growth of 22% year-over-year and beat EPS estimates for three consecutive quarters, though it remains unprofitable with a net income margin of -17.77%. Recent positive developments include FDA clearance for its ECG-MR AI product and expanded data licensing agreements, fueling investor optimism in the healthtech sector.
The investment outlook is cautiously optimistic, driven by strong analyst support (64% buy ratings) and a consensus price target of $72.60, implying modest upside. Key opportunities include accelerating adoption of AI-powered diagnostics and strategic acquisitions, but risks persist from persistent cash burn, insider selling, and intense competition in the precision medicine space.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Nano Dimension Ltd - ADR
Nano Dimension Ltd is engaged in research and development of a three-dimensional printer that prints electronic circuit boards, also known as printed circuit boards, and ink materials and products based on nanotechnology. Its products consist of two main product lines - Dragonfly 2020 3D printer and proprietary ink products. The company's Dragonfly 2020 3D printer currently in development uses proprietary ink and integrated software to quickly create fully functioning PCB prototypes. Geographically, it generates maximum revenue from the USA followed by the Asia Pacific and Europe and Israel. It serves the Commercial, Research and Printing services industries.
Read more on NNDM →About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →
